Humana Inc.

484.87-28.41-5.53%Vol 1.52M1Y Perf 27.93%
Feb 2nd, 2023 13:03 DELAYED
BID484.77 ASK485.44
Open499.13 Previous Close513.28
Pre-Market501.66 After-Market-
 -11.62 -2.26%  - -
Target Price
602.61 
Analyst Rating
Strong Buy 1.31
Potential %
23.96 
Finscreener Ranking
★★★     49.86
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     45.98
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★     59.87
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★+     35.24
Price Range Ratio 52W %
53.76 
Earnings Rating
Strong Sell
Market Cap61.38B 
Earnings Date
1st Feb 2023
Alpha0.01 Standard Deviation0.08
Beta0.80 

Today's Price Range

483.41506.51

52W Range

384.39571.30

5 Year PE Ratio Range

10.4065.20

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
2.79%
1 Month
0.21%
3 Months
-8.27%
6 Months
7.29%
1 Year
27.93%
3 Years
52.65%
5 Years
85.63%
10 Years
599.05%

TickerPriceChg.Chg.%
HUM484.87-28.4066-5.53
AAPL150.154.71503.24
GOOG107.225.79005.71
MSFT261.849.09003.60
XOM111.79-2.9548-2.58
WFC47.530.50011.06
JNJ164.08-0.8400-0.51
FB196.640.99000.51
GE83.721.40001.70
JPM139.41-0.1800-0.13
 
ProfitabilityValueIndustryS&P 500US Markets
-
4.30
-
4.40
4.00
RevenueValueIndustryS&P 500US Markets
70.43B
556.33
11.84
10.13
DividendsValueIndustryS&P 500US Markets
0.65
3.15
10.60
13.72
Payout ratio9.00
Earnings HistoryEstimateReportedSurprise %
Q04 20221.461.6210.96
Q03 20226.256.8810.08
Q02 20227.678.6713.04
Q01 20226.838.0417.72
Q04 20211.231.240.81
Q03 20214.614.834.77
Q02 20216.866.890.44
Q01 20217.217.676.38
Earnings Per EndEstimateRevision %Trend
12/2022 QR1.47-31.94Negative
12/2022 FY25.050.16Positive
3/2023 QR8.52-2.18Negative
12/2023 FY27.970.00-
Next Report Date-
Estimated EPS Next Report1.46
Estimates Count9
EPS Growth Next 5 Years %14.10
Volume Overview
Volume1.52M
Shares Outstanding126.60K
Shares Float126.27M
Trades Count35.48K
Dollar Volume749.88M
Avg. Volume1.25M
Avg. Weekly Volume1.58M
Avg. Monthly Volume1.15M
Avg. Quarterly Volume1.03M

Humana Inc. (NYSE: HUM) stock closed at 513.28 per share at the end of the most recent trading day (a 0.31% change compared to the prior day closing price) with a volume of 1.91M shares and market capitalization of 61.38B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 48700 people. Humana Inc. CEO is Bruce D. Broussard.

The one-year performance of Humana Inc. stock is 27.93%, while year-to-date (YTD) performance is 0.21%. HUM stock has a five-year performance of 85.63%. Its 52-week range is between 384.385 and 571.3, which gives HUM stock a 52-week price range ratio of 53.76%

Humana Inc. currently has a PE ratio of 22.30, a price-to-book (PB) ratio of 3.84, a price-to-sale (PS) ratio of 0.87, a price to cashflow ratio of 6.50, a PEG ratio of 2.32, a ROA of 6.30%, a ROC of -% and a ROE of 18.70%. The company’s profit margin is 4.00%, its EBITDA margin is -%, and its revenue ttm is $70.43 Billion , which makes it $556.33 revenue per share.

Of the last four earnings reports from Humana Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.46 for the next earnings report. Humana Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Humana Inc. is Strong Buy (1.31), with a target price of $602.61, which is +23.96% compared to the current price. The earnings rating for Humana Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Humana Inc. has a dividend yield of 0.65% with a dividend per share of $3.15 and a payout ratio of 9.00%.

Humana Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 9.20, ATR14 : 13.92, CCI20 : 222.88, Chaikin Money Flow : -0.04, MACD : -2.23, Money Flow Index : 77.25, ROC : 4.46, RSI : 57.38, STOCH (14,3) : 69.49, STOCH RSI : 1.00, UO : 49.15, Williams %R : -30.51), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Humana Inc. in the last 12-months were: Bruce D. Broussard (Option Excercise at a value of $13 670 312), Bruce D. Broussard (Sold 16 000 shares of value $8 819 004 ), Cynthia H. Zipperle (Option Excercise at a value of $0), David A. Jones (Sold 15 000 shares of value $7 525 800 ), Heather M. Carroll Cox (Option Excercise at a value of $0), Jorge S. Mesquita (Option Excercise at a value of $0), Joseph C. Ventura (Option Excercise at a value of $1 106 210), Joseph C. Ventura (Sold 4 381 shares of value $2 404 755 ), Marcy S. Klevorn (Option Excercise at a value of $0), Samir Deshpande (Option Excercise at a value of $2 736 953), Samir Deshpande (Sold 11 919 shares of value $6 224 217 ), Susan D. Schick (Option Excercise at a value of $0), Susan M. Diamond (Option Excercise at a value of $1 422 797), Susan M. Diamond (Sold 5 623 shares of value $3 184 030 ), Timothy Alan Wheatley (Option Excercise at a value of $5 195 662), Timothy Alan Wheatley (Sold 22 570 shares of value $12 779 377 ), Timothy S. Huval (Option Excercise at a value of $2 578 540), Timothy S. Huval (Sold 11 549 shares of value $5 616 284 ), Vishal Agrawal (Option Excercise at a value of $0), William H Shrank (Option Excercise at a value of $0), William Kevin Fleming (Option Excercise at a value of $3 619 973), William Kevin Fleming (Sold 14 367 shares of value $7 754 021 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
14 (77.78 %)
14 (77.78 %)
13 (76.47 %)
Moderate Buy
2 (11.11 %)
2 (11.11 %)
2 (11.76 %)
Hold
2 (11.11 %)
2 (11.11 %)
2 (11.76 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.31
Strong Buy
1.31
Strong Buy
1.32

Humana Inc.

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

CEO: Bruce D. Broussard

Telephone: +1 502 580-1000

Address: 500 West Main Street, Louisville 40202, KY, US

Number of employees: 48 700

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

59%41%

TipRanks News for HUM

Thu, 02 Feb 2023 15:25 GMT Humana (HUM) Receives a Rating Update from a Top Analyst

- TipRanks. All rights reserved.

Mon, 30 Jan 2023 12:18 GMT Humanas (HUM) New Defense Contract Extension Could Be Worth $16.26B

- TipRanks. All rights reserved.

Thu, 03 Nov 2022 12:42 GMT Analysts Offer Insights on Healthcare Companies: Humana (HUM), Premier (PINC) and Bausch + Lomb Corporation (BLCO)

- TipRanks. All rights reserved.

Mon, 19 Sep 2022 04:30 GMT Analysts Offer Insights on Healthcare Companies: Humana (HUM), Innate Pharma (IPHA) and scPharmaceuticals (SCPH)

- TipRanks. All rights reserved.

Sat, 30 Jul 2022 01:50 GMT RBC Capital Believes Humana (HUM) Wont Stop Here

- TipRanks. All rights reserved.

Thu, 28 Jul 2022 12:15 GMT Analysts Offer Insights on Healthcare Companies: Amedisys (AMED), Humana (HUM) and Teladoc (TDOC)

- TipRanks. All rights reserved.

News

Stocktwits